Da: Better World Books Ltd, Dunfermline, Regno Unito
Prima edizione
EUR 6,69
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Very Good. 1st Edition. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Da: Better World Books Ltd, Dunfermline, Regno Unito
Prima edizione
EUR 6,69
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: Good. 1st Edition. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Condizione: New.
EUR 53,55
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. x + 334 Illus.
EUR 61,49
Quantità: 2 disponibili
Aggiungi al carrelloHardback. Condizione: New. Over five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people world-wide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive. For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of anti-hypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against. Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures including coronary artery bypass grafting, valve replacement surgery, congenital heart disease treatment, aortic surgery, cardiac transplantation and post-carotid endarterectomy. Another examines special risks during pregnancy. Lastly, the book reviews our understanding of childhood stroke -- perinatal, infants and older children, adolescents and young adults - and presents current best practice recommendations for this most challenging group of patients.
EUR 49,03
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
EUR 52,84
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Condizione: New. pp. x + 334.
Condizione: As New. Unread book in perfect condition.
EUR 82,61
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread copy in mint condition.
EUR 82,70
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Brand New.
EUR 71,21
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. x + 334.
Hardback. Condizione: New. Over five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people world-wide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive. For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of anti-hypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against. Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures including coronary artery bypass grafting, valve replacement surgery, congenital heart disease treatment, aortic surgery, cardiac transplantation and post-carotid endarterectomy. Another examines special risks during pregnancy. Lastly, the book reviews our understanding of childhood stroke -- perinatal, infants and older children, adolescents and young adults - and presents current best practice recommendations for this most challenging group of patients.
EUR 54,86
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Over five million people die from stroke each year. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly.
EUR 45,42
Quantità: 4 disponibili
Aggiungi al carrelloHardback. Condizione: New. New Book, Direct from Publisher.
Hardback. Condizione: New. Over five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people world-wide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive. For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of anti-hypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against. Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures including coronary artery bypass grafting, valve replacement surgery, congenital heart disease treatment, aortic surgery, cardiac transplantation and post-carotid endarterectomy. Another examines special risks during pregnancy. Lastly, the book reviews our understanding of childhood stroke -- perinatal, infants and older children, adolescents and young adults - and presents current best practice recommendations for this most challenging group of patients.
EUR 56,96
Quantità: 2 disponibili
Aggiungi al carrelloHardback. Condizione: New. Over five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people world-wide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive. For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of anti-hypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against. Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures including coronary artery bypass grafting, valve replacement surgery, congenital heart disease treatment, aortic surgery, cardiac transplantation and post-carotid endarterectomy. Another examines special risks during pregnancy. Lastly, the book reviews our understanding of childhood stroke -- perinatal, infants and older children, adolescents and young adults - and presents current best practice recommendations for this most challenging group of patients.
Da: Chiron Media, Wallingford, Regno Unito
EUR 179,38
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardcover. Condizione: New.
Da: Chiron Media, Wallingford, Regno Unito
EUR 179,38
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardcover. Condizione: New.
Lingua: Inglese
Editore: Elsevier Science Ltd 2014-02-01, 2014
ISBN 10: 0702040886 ISBN 13: 9780702040887
Da: Chiron Media, Wallingford, Regno Unito
EUR 179,38
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardcover. Condizione: New.
EUR 178,03
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. Like New. book.
Da: Majestic Books, Hounslow, Regno Unito
EUR 201,43
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. 736.
Da: Majestic Books, Hounslow, Regno Unito
EUR 201,43
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. 760.
Da: Majestic Books, Hounslow, Regno Unito
EUR 201,43
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. 816.
Da: Revaluation Books, Exeter, Regno Unito
EUR 208,01
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 500 pages. 10.25x8.00x1.50 inches. In Stock.
Da: Revaluation Books, Exeter, Regno Unito
EUR 208,21
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 584 pages. 10.25x8.00x1.50 inches. In Stock.
Da: Revaluation Books, Exeter, Regno Unito
EUR 208,99
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 816 pages. 10.25x8.00x1.75 inches. In Stock.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 760.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 736.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 816.